Literature DB >> 8116170

Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).

J H van der Kolk1, H C Kalsbeek, E van Garderen, T Wensing, H J Breukink.   

Abstract

The records of 21 horses with an adenoma of the pars intermedia of the pituitary gland were reviewed. The animals comprised nine Dutch warmblood horses and 12 ponies. They ranged in age from 12 to 30 years (mean +/- sem 21 +/- 1.3 years) for 20 of the horses, and comprised 13 geldings and eight mares. All the animals showed hirsutism. In 1991, nine horses were diagnosed as having the adenoma, equivalent to 0.5 per cent of the horses examined in 1991. The mean +/- sem survival time of four of the horses (from discharge to the development of complications which required euthanasia) was 192 +/- 59 days (range 120 to 368 days). Routine biochemical measurements were within their normal ranges except for a high alkaline phosphatase activity (768 +/- 487 iu/litre) and a high plasma glucose concentration (7.8 +/- 0.9 mmol/litre) in 16 of the horses; only six had a glucose concentration above 9.0 mmol/litre. The basal plasma concentration of adrenocorticotrophic hormone (ACTH) in the diseased horses was at least 191 pg/ml. Eight of the horses had mean plasma cortisol concentrations before and after the administration of 25 iu of synthetic ACTH1-24 of 168 +/- 21 (range 74 to 248) and 478 +/- 58 nmol/litre (range 248 to 771), respectively. Analysis of the urine of five of the horses revealed a mean specific gravity of 1.034 +/- 0.0034 (range 1.025 to 1.045).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8116170

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

1.  Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.

Authors:  James L Carmalt; Cheryl L Waldner; Andrew L Allen
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

2.  Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy.

Authors:  Jessica S Fortin; Ashley A Hetak; Kelsey E Duggan; Caroline M Burglass; Hailey B Penticoff; Harold C Schott
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

Review 3.  Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management.

Authors:  Caroline W Spelta
Journal:  Vet Med (Auckl)       Date:  2015-08-20

4.  Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.

Authors:  Jessica S Fortin; Matthew J Benskey; Keith J Lookingland; Jon S Patterson; Erin B Howey; John L Goudreau; Harold C Schott
Journal:  BMC Vet Res       Date:  2020-09-25       Impact factor: 2.741

5.  Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction.

Authors:  Ruth A Morgan; John A Keen; Natalie Homer; Mark Nixon; Anna M McKinnon-Garvin; Jodie A Moses-Williams; Sarah R Davis; Patrick W F Hadoke; Brian R Walker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.